| Evaluation of prescription pattern in Osun state (Southwest) Nigeria CP Babalola, SA Awoleye, JO Akinyemi, OA Kotila J Public Health Epidemiol 3 (3), 94-98, 2011 | 85 | 2011 |
| Simultaneous spectrophotometric determination of trimethoprim and sulphamethoxazole following charge-transfer complexation with chloranilic acid OA Adegoke, CP Babalola, OA Kotila, O Obuebhor Arabian Journal of Chemistry 10, S3848-S3860, 2017 | 30 | 2017 |
| Causes and remedies for low research productivity among postgraduate scholars and early career researchers on non-communicable diseases in Nigeria MM Oluwasanu, N Atara, W Balogun, O Awolude, O Kotila, T Aniagwu, ... BMC research notes 12, 1-6, 2019 | 20 | 2019 |
| Experimental determination of the physicochemical properties of lumefantrine CP Babalola African journal of medicine and medical sciences 42 (3), 209-214, 2013 | 19 | 2013 |
| Quinoline antimalarials increase the antibacterial activity of ampicillin OA Olateju, CP Babalola, OO Olubiyi, OA Kotila, DA Kwasi, AO Oaikhena, ... Frontiers in Microbiology 12, 556550, 2021 | 15 | 2021 |
| Implementing oncology clinical trials in Nigeria: A model for Capacity building. A Ntekim, A Ibraheem, A Sofoluwe, T Adepoju, M Oluwasanu, T Aniagwu, ... BMC Health Services Research 20 (713), 2020 | 15 | 2020 |
| A novel derivatization ultraviolet spectrophotometric method for the determination of dihydroartemisinin using p-nitroaniline CP Babalola, I Oluwalana, OA Kotila, OA Adegoke, YT Kolade, SJ Ameh Tropical Journal of Pharmaceutical Research 13 (1), 127-133, 2014 | 11 | 2014 |
| N-acetyltransferase 2 enzyme genotype–phenotype discordances in both HIV-negative and HIV-positive Nigerians OA Kotila, OI Fawole, OI Olopade, AI Ayede, AG Falusi, CP Babalola Pharmacogenetics and genomics 29 (5), 106-113, 2019 | 7 | 2019 |
| Spectrophotometric studies of the charge-transfer complexation between lumefantrine and chloranilic acid in acetonitrile OA Adegoke, CP Babalola, POK Isaac, OA Kotila ACTA Pharmaceutica Sciencia 53 (1), 135-149, 2011 | 7 | 2011 |
| ARETTA: Assessing response to neoadjuvant taxotere and subcutaneous trastuzumab in Nigerian women with HER2-positive breast cancer: A study protocol AI Ntekim, A Ibraheem, AA Sofoluwe, O Kotila, C Babalola, T Karrison, ... JCO global oncology 6, 983-990, 2020 | 5 | 2020 |
| Self-reported sulphonamide hypersensitivity reactions in adults living in Ibadan, Nigeria: A cross-sectional, community-based study AR Mary, KA Olayinka, AM Onoja, F Olufunmilayo, FG Adeyinka, ... Nigerian Medical Journal 56 (6), 404-410, 2015 | 5 | 2015 |
| Disposition of quinine and its major metabolite, 3-hydroxyquinine in patients with liver diseases CP Babalola, OA Kotila, PAF Dixon, AE Oyewo Res Pharm Biotech 3 (3), 25-9, 2011 | 4 | 2011 |
| Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria JN Nwogu, SO Ngene, CP Babalola, A Olagunju, A Owen, SH Khoo, ... AIDS Research and Therapy 19 (1), 35, 2022 | 3 | 2022 |
| Toxicological effect of sub-therapeutic, therapeutic and overdose regimens of halofantrine hydrochloride on male albino rats CP Babalola, DN Kanu, GO Okafor, A Wumi, O Ajayi, OA Kotila Pharmacologia 4, 180-185, 2013 | 3 | 2013 |
| In-vitro interaction studies of lumefantrine with antacids CP Babalola, O Ajayi, O Kotila, S Ameh Pharmacie Globale (IJCP) 3 (1), 1-4, 2012 | 3 | 2012 |
| Oncology training needs assessment among health care professionals in Nigeria PO Adejumo, MM Oluwasanu, A Ntekim, OA Awolude, OA Kotila, ... JCO Global Oncology 8, e2200017, 2022 | 2 | 2022 |
| Effect of Caffeine-Containing Beverages on Physicochemical and Release Properties of Halofantrine CP Babalola, YT Kolade, MA Adeyemo, OA Kotila, SJ Ameh, TA Adelakun, ... Global Journal of Medical Research: B Pharma, Drug Discovery, Toxicology and …, 2014 | 2 | 2014 |
| Effect of Artesunate on the Urinary Excretion of Cloxacillin in Healthy Subjects. CP Babalola, EO Olori, OA Kotila, O Falade, YT Kolade, BO Sylva Nigerian Journal of Pharmaceutical Research 7 (1), 29-36, 2009 | 2 | 2009 |
| Towards the Development of Blueprint for Health Security in Nigeria by 2050: A Review of Drug Development, Supply of Quality Medicines and Treatment Issues. OA Odeku, R Adisa, OA Adetunji, MA Durowaiye, K O.A African Journal of Medicine and Medical Sciences 48 (Supplement), 185-193, 2019 | 1 | 2019 |
| Building capacity for drug development process in Africa‒A workable model CP Babalola, O Kotila, BB Samuel, O Adetunji, GO Gbotosho, JO Moody, ... Pharmacy Education 24 (1), 1-12, 2024 | | 2024 |
Chinedum BabalolaProfessor of Pharmaceutical Chemistry/Pharmacokinetics, University of IbadanVerified email at mail.ui.edu.ng
